Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

BIIB

BIOGEN INC.

CIK 0000875045 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$216.78
↑ 2.43 (1.13%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Technicals

Key stats

Market Cap
$32.03B
P/E Ratio
23.35
EPS
8.83
Dividend Yield
Not covered
52W Position
94%
Beta
0.27

Valuation multiples

Fwd P/E
17.21
PEG
5.06
P/B
1.72
P/S
3.22
EV/Revenue
3.86
ROE
7.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 94%
$131.52$222.15

Latest Financials

2025-12-31 FY
Revenue
$9.89B
Net Income
$1.29B
Total Assets
$29.44B
Free Cash Flow
$2.05B

Recent news